These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11394943)

  • 21. Pharmacokinetics of tobramycin in ducks and sex-related differences.
    Dimitrova D; Moutafchieva R; Kanelov I; Dinev T; Lashev L
    Vet J; 2009 Mar; 179(3):462-4. PubMed ID: 18006340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic studies on tobramycin in horses.
    Hubenov H; Bakalov D; Krastev S; Yanev S; Haritova A; Lashev L
    J Vet Pharmacol Ther; 2007 Aug; 30(4):353-7. PubMed ID: 17610409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
    Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of intraperitoneally instilled aminophylline, terbutaline and tobramycin in pigs.
    Asheim P; Spigset O; Aasarød K; Walstad RA; Uggen PE; Zahlsen K; Aadahl P
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):243-8. PubMed ID: 18005375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
    Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
    Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasting increases tobramycin oral absorption in mice.
    De Leo L; Di Toro N; Decorti G; Malusà N; Ventura A; Not T
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1644-6. PubMed ID: 20086144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model.
    Zhang N; Ping Q; Huang G; Han X; Cheng Y; Xu W
    J Nanosci Nanotechnol; 2006; 6(9-10):2959-66. PubMed ID: 17048504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
    Massie J; Cranswick N
    J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J; Hoyer H; Bernkop-Schnürch A
    Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin.
    Marchand S; Grégoire N; Brillault J; Lamarche I; Gobin P; Couet W
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6646-7. PubMed ID: 26239992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
    Hu LD; Tang X; Cui FD
    Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes.
    Jin SX; Bi DZ; Wang J; Wang YZ; Hu HG; Deng YH
    Pharmazie; 2005 Nov; 60(11):840-3. PubMed ID: 16320946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside.
    Zhang X; Lü S; Han J; Sun S; Wang L; Li Y
    Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
    Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of tobramycin in cats.
    Jernigan AD; Hatch RC; Wilson RC
    Am J Vet Res; 1988 May; 49(5):608-12. PubMed ID: 3395005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats.
    Bargoni A; Cavalli R; Caputo O; Fundarò A; Gasco MR; Zara GP
    Pharm Res; 1998 May; 15(5):745-50. PubMed ID: 9619784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.